Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Agenus Inc (NASDAQ:AGEN)

6.42
Delayed Data
As of Aug 30
 -0.05 / -0.77%
Today’s Change
2.61
Today|||52-Week Range
7.45
+41.41%
Year-to-Date
4 Momentum Stocks You Should Watch Now
Aug 30 / TheStreet.com - Paid Partner Content
2 Cancer Therapy Stocks That Are Ridiculously Cheap Right Now
Aug 18 / MotleyFool.com - Paid Partner Content

Today’s Trading

Previous close6.47
Today’s open6.44
Day’s range6.37 - 6.62
Volume1,044,354
Average volume (3 months)1,055,028
Market cap$562.9M
Dividend yield--
Data as of 4:00pm ET, 08/30/2016

Growth & Valuation

Earnings growth (last year)-59.15%
Earnings growth (this year)-12.21%
Earnings growth (next 5 years)+1.00%
Revenue growth (last year)+255.67%
P/E ratioNM
Price/Sales14.31
Price/Book7.90

Competitors

 Today’s
change
Today’s
% change
ATRAAtara Biotherapeutic...+0.21+1.07%
RTRXRetrophin Inc-0.02-0.12%
ADAPAdaptimmune Therapeu...+0.05+0.70%
EDITEditas Medicine Inc+0.29+1.66%
Data as of 4:00pm ET, 08/30/2016

Financials

Next reporting dateOctober 20, 2016
EPS forecast (this quarter)-$0.29
Annual revenue (last year)$24.8M
Annual profit (last year)-$87.9M
Net profit margin-354.12%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman &
Chief Executive Officer
Garo H. Armen
Chief Financial &
Accounting Officer
Christine M. Klaskin
Corporate headquarters
Lexington, Massachusetts

Forecasts

Search for Jobs